We are live on
!
Find out more
AAP
Arax Advisory Partners Portfolio holdings
AUM
$3.54B
1-Year Est. Return
19.14%
This Fund
S&P 500
This Quarter
Est. Return
+8.62%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
–
AUM
$6.97B
AUM Growth
+$4.79B
(+220%)
Cap. Flow
+$6.91B
Cap. Flow
% of AUM
99.25%
Top 10 Holdings %
Top 10 Hldgs %
36.51%
Holding
4,400
New
1,371
Increased
1,984
Reduced
143
Closed
794
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 100 ETF
OEF
|
+$2.43B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.24B |
| 3 |
DFAI
Dimensional International Core Equity Market ETF
DFAI
|
+$202M |
| 4 |
American Century Diversified Corporate Bond ETF
KORP
|
+$152M |
| 5 |
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Growth ETF
VUG
|
+$91.2M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$62.6M |
| 3 |
AXON
Axon Enterprise
AXON
|
+$58.1M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$46.5M |
| 5 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$44.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.48% |
| 2 | Financials | 8.05% |
| 3 | Industrials | 7.03% |
| 4 | Consumer Discretionary | 6.62% |
| 5 | Healthcare | 6.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Cipher Digital
CIFR
$7.13B
| $6.14K | ﹤0.01% |
+488
| New | +$3.68K |
|
2802
Cohen & Steers Tax-Advantaged Preferred Securities & Income Fund
PTA
$1.05B
| $6.12K | ﹤0.01% |
+300
| New | +$6.06K |
|
2803
Protagonist Therapeutics
PTGX
$9.44B
| $6.11K | ﹤0.01% |
+92
| New | +$5.23K |
|
2804
Dyne Therapeutics
DYN
$4.9B
| $6.11K | ﹤0.01% |
483
+253
| +110% | +$2.89K |
|
2805
Clean Energy Fuels
CLNE
$346M
| $6.09K | ﹤0.01% |
+2,361
| New | +$5.53K |
|
2806
MGP Ingredients
MGPI
$375M
| $6.07K | ﹤0.01% |
251
+12
| +5% | +$348 |
|
2807
PLDT
PHI
$4.33B
| $6.05K | ﹤0.01% |
323
+174
| +117% | +$3.74K |
|
2808
Meridian
MRBK
$234M
| $6.05K | ﹤0.01% |
+383
| New | +$5.75K |
|
2809
CEVA Inc
CEVA
$1.08B
| $6K | ﹤0.01% |
227
+186
| +454% | +$4.33K |
|
2810
Franklin Financial Services
FRAF
$280M
| $5.98K | ﹤0.01% |
+130
| New | +$5.61K |
|
|
CCRN
2811
DELISTED
Cross Country Healthcare
CCRN
| $5.98K | ﹤0.01% |
+421
| New | +$5.56K |
|
2812
Kadant
KAI
$3.99B
| $5.95K | ﹤0.01% |
20
+17
| +567% | +$5.55K |
|
2813
Astrana Health
ASTH
$1.77B
| $5.9K | ﹤0.01% |
208
+155
| +292% | +$4.2K |
|
2814
Investar Holding Corp
ISTR
$414M
| $5.87K | ﹤0.01% |
+253
| New | +$5.68K |
|
|
MGRM
2815
DELISTED
Monogram Orthopaedics
MGRM
| $5.87K | ﹤0.01% |
+1,000
| New | +$5.34K |
|
2816
Viemed Healthcare
VMD
$371M
| $5.85K | ﹤0.01% |
+861
| New | +$5.83K |
|
2817
LifeMD
LFMD
$172M
| $5.84K | ﹤0.01% |
+860
| New | +$7.1K |
|
|
LNKB
2818
DELISTED
LINKBANCORP
LNKB
| $5.84K | ﹤0.01% |
+819
| New | +$5.94K |
|
|
BKV
2819
BKV Corp
BKV
$2.68B
| $5.83K | ﹤0.01% |
+252
| New | +$5.49K |
|
2820
eHealth
EHTH
$43.9M
| $5.83K | ﹤0.01% |
+1,352
| New | +$5.19K |
|
2821
UFP Technologies
UFPT
$2.43B
| $5.79K | ﹤0.01% |
+29
| New | +$6.38K |
|
2822
Array Technologies
ARRY
$855M
| $5.79K | ﹤0.01% |
710
+434
| +157% | +$3.29K |
|
2823
Ceco Environmental
CECO
$4.14B
| $5.79K | ﹤0.01% |
+113
| New | +$4.78K |
|
2824
BlueLinx
BXC
$706M
| $5.77K | ﹤0.01% |
+79
| New | +$6.22K |
|
2825
Gain Therapeutics
GANX
$77.6M
| $5.75K | ﹤0.01% |
3,250
+750
| +30% | +$1.26K |
|
Similar funds
TYCC
TH
BCP
WWA
VPC
BPS
TCM
DILIC
Arax Advisory Partners's Q3 2025 Portfolio in Review
As of Q3 2025, Arax Advisory Partners held 4,400 positions worth $6.97B, up 220% from $2.18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Arax Advisory Partners deployed $6.91B of net new capital in Q3 2025, opening 1,371 new positions and adding to 1,984 existing holdings. Its largest new stake was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 6.5% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Axon Enterprise, an estimated $58.1M trimmed.
- Arax Advisory Partners's largest Q3 2025 buy was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
- Arax Advisory Partners added most to iShares S&P 100 ETF in Q3 2025, an estimated $2.43B increase.
- Arax Advisory Partners's biggest Q3 2025 reduction was Axon Enterprise, cutting an estimated $58.1M.
- Arax Advisory Partners fully exited Vanguard Morningstar Growth ETF in Q3 2025, selling an estimated $91.2M.
- Arax Advisory Partners's ten largest holdings make up 37% of its $6.97B portfolio in Q3 2025.
- Arax Advisory Partners opened 1,371 new positions and closed 794 in Q3 2025.
- Arax Advisory Partners's portfolio value rose 220% quarter-over-quarter to $6.97B.
Based on Arax Advisory Partners's 13F filing for Q3 2025, filed 14 Nov 2025.